Cell-state-specific metabolic dependency in hematopoiesis and leukemogenesis

Area of Science:

• Cellular metabolism
• Hematopoiesis
• Cancer biology

Background:

• Glucose metabolism, particularly the balance between oxidative and nonoxidative pathways, is crucial for cellular function and disease.
• Hematopoiesis, the process of blood cell formation, relies on precise metabolic regulation.
• Altered glucose metabolism is a hallmark of many cancers, including leukemia.

Purpose of the Study:

• To investigate the specific roles of key glycolytic enzymes, pyruvate kinase M2 (PKM2) and lactate dehydrogenase A (LDHA), in normal hematopoiesis and leukemia.
• To determine if modulating glucose metabolism can selectively target leukemic cells while preserving normal hematopoietic stem cells (HSCs) and progenitors.

Main Methods:

• Utilized gene deletion strategies to specifically remove PKM2 and LDHA in mouse models.
• Assessed the impact of enzyme deficiencies on HSC and progenitor function during normal hematopoiesis.
• Evaluated the effect of PKM2 and LDHA deletion on leukemia initiation and progression.

Main Results:

• PKM2 deficiency impaired progenitor function and reduced biosynthetic intermediates but did not affect HSCs.
• LDHA deletion significantly inhibited both HSC and progenitor function during hematopoiesis.
• Leukemia initiation was suppressed by the absence of either PKM2 or LDHA, irrespective of the affected cell type (HSC or progenitor).
• Cell-state-specific metabolic responses observed in normal hematopoiesis were not applicable to leukemia.

Conclusions:

• Targeting PKM2 or LDHA offers a potential therapeutic strategy for leukemia.
• Fine-tuning glycolysis may allow for selective elimination of leukemic cells while preserving essential HSC function.
• Metabolic interventions in leukemia may overcome cell-state-specific resistance mechanisms observed in normal hematopoiesis.